Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas

被引：6
|
作者：
Yilmaz, Elif [1 ]
Lakhotia, Rahul [2 ]
Pittaluga, Stefania [3 ]
Muppidi, Jagan R. [2 ]
Phelan, James D. [2 ]
Evans, Sarah [2 ]
Pradhan, Amynah [2 ]
Hillsman, Amy [2 ]
Steinberg, Seth M. [4 ]
Jaffe, Elaine S. [3 ]
Wilson, Wyndham H. [2 ]
Roschewski, Mark [2 ]
Melani, Christopher [2 ]
机构：
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, MD USA
[2] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4504
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
    Dugan, James P.
    Coleman, Carrie B.
    Haverkos, Bradley
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [32] Epstein-Barr Virus (EBV)-positive Sporadic Burkitt Lymphoma An Age-related Lymphoproliferative Disorder?
    Satou, Akira
    Asano, Naoko
    Nakazawa, Atsuko
    Osumi, Tomoo
    Tsurusawa, Masahito
    Ishiguro, Atsushi
    Elsayed, Ahmed Ali
    Nakamura, Naoya
    Ohshima, Koichi
    Kinoshita, Tomohiro
    Nakamura, Shigeo
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (02) : 227 - 235
  • [33] Prognostic Significance of Circulating Epstein-Barr Virus (EBV) DNA in Non-Hodgkin's Lymphoma
    Kang, Myoung Joo
    Cho, Yoo Jin
    Ahn, Heui June
    Kim, Shin
    Lee, Dae Ho
    Kim, Sang We
    Chi, Hyun-Sook
    Suh, Cheolwon
    BLOOD, 2009, 114 (22) : 768 - 768
  • [34] Determination of Frequency of Epstein-Barr Virus in Non-Hodgkin Lymphomas Using EBV Latent Membrane Protein 1 (EBV-LMP1) Immunohistochemical Staining
    Ishtiaq, Sheeba
    Hassan, Usman
    Mushtaq, Sajid
    Akhtar, Noreen
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3963 - 3967
  • [35] EPSTEIN-BARR VIRUS (EBV) ANTIBODIES IN CHILDREN WITH NON-HODGKINS LYMPHOMAS
    ROUBALOVA, K
    WEINREB, M
    ROUBAL, J
    KODET, R
    KOUTECKY, J
    VONKA, V
    ACTA VIROLOGICA, 1988, 32 (04) : 339 - 348
  • [36] A common pathogenetic denominator of Epstein-Barr virus (EBV) positive and negative Hodgkin's disease (HD)
    Knecht, H
    McQuain, C
    Berger, C
    Rothenberger, S
    Drexler, HG
    Ouesenberry, PJ
    Odermatt, BF
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 80 - 80
  • [37] Distinct immunopathological mechanisms of EBV-positive and EBV-negative posttransplant lymphoproliferative disorders
    Nakid-Cordero, Cecilia
    Choquet, Sylvain
    Gauthier, Nicolas
    Balegroune, Noureddine
    Tarantino, Nadine
    Morel, Veronique
    Arzouk, Nadia
    Burrel, Sonia
    Rousseau, Geraldine
    Charlotte, Frederic
    Larsen, Martin
    Vieillard, Vincent
    Autran, Brigitte
    Leblond, Veronique
    Guihot, Amelie
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (08) : 2846 - 2863
  • [38] Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients
    Spacek, Martin
    Hubacek, Petr
    Markova, Jana
    Zajac, Miroslav
    Vernerova, Zdenka
    Kamaradova, Katerina
    Stuchly, Jan
    Kozak, Tomas
    APMIS, 2011, 119 (01) : 10 - 16
  • [39] Expression of Galectin-1 by EBV-Positive Lymphoproliferative Disorders
    Chen, B. J.
    Ouyang, J.
    Sinha, P.
    Shipp, M. A.
    Fletcher, C. D. M.
    Rodig, S. J.
    MODERN PATHOLOGY, 2012, 25 : 329A - 329A
  • [40] Are posttransplant lymphoproliferative disorders (PTLDs) not associated to Epstein-Barr virus (EBV) a distinct entity?
    Leblond, V
    Charlotte, F
    Davi, F
    Dorent, R
    Bitker, MO
    Raphael, M
    BLOOD, 1996, 88 (10) : 1032 - 1032
12345